Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
BTIG sees potential dividend cuts in other stocks after Chimera's reduction » 14:01
09/22/22
09/22
14:01
09/22/22
14:01
CIM

Chimera

$6.76 /

-0.805 (-10.65%)

BTIG analyst Eric Hagen…

BTIG analyst Eric Hagen notes that Chimera's stock is off 10% intraday in response to cutting the dividend to 23c per quarter from 33c. The analyst thinks it was becoming challenging for Chimera to support a hurdle rate above 15%, particularly as wider securitization spreads create pressure on returns, and tighter liquidity conditions restrict some flexibility for levered investors. Further, he believes there's read-through to potential dividend cuts in other stocks, although either way, he considers economic return to be the primary metric driving valuations for mortgage REITs. The analyst has a Neutral rating on the shares.

ShowHide Related Items >><<
CIM Chimera
$6.76 /

-0.805 (-10.65%)

CIM Chimera
$6.76 /

-0.805 (-10.65%)

07/17/22 Barclays
Chimera price target lowered to $9 from $11 at Barclays
04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$6.76 /

-0.805 (-10.65%)

CIM Chimera
$6.76 /

-0.805 (-10.65%)

CIM Chimera
$6.76 /

-0.805 (-10.65%)

Hot Stocks
Chimera declares Q3 dividend of 23c per share, down from prior 33c per share » 13:52
09/22/22
09/22
13:52
09/22/22
13:52
CIM

Chimera

$6.79 /

-0.775 (-10.25%)

Earlier, Chimera…

Earlier, Chimera announced that its board of directors declared a third quarter cash dividend of 23c per share of common stock. The dividend is payable October 31 to shareholders of record on September 30, and the ex-dividend date is September 29, the company noted. Previously, Chimera had declared a second quarter cash dividend of 33c per common share, which was payable July 28 to common stockholders of record on June 30. In afternoon trading, Chimera shares are down 80c, or 10.5%, to $6.76.

ShowHide Related Items >><<
CIM Chimera
$6.79 /

-0.775 (-10.25%)

CIM Chimera
$6.79 /

-0.775 (-10.25%)

07/17/22 Barclays
Chimera price target lowered to $9 from $11 at Barclays
04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$6.79 /

-0.775 (-10.25%)

CIM Chimera
$6.79 /

-0.775 (-10.25%)

CIM Chimera
$6.79 /

-0.775 (-10.25%)

Hot Stocks
Chimera falls -9.7% » 10:00
09/22/22
09/22
10:00
09/22/22
10:00
CIM

Chimera

$6.83 /

-0.73 (-9.66%)

Chimera is down -9.7%, or…

Chimera is down -9.7%, or -73c to $6.83.

ShowHide Related Items >><<
CIM Chimera
$6.83 /

-0.73 (-9.66%)

CIM Chimera
$6.83 /

-0.73 (-9.66%)

07/17/22 Barclays
Chimera price target lowered to $9 from $11 at Barclays
04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$6.83 /

-0.73 (-9.66%)

CIM Chimera
$6.83 /

-0.73 (-9.66%)

CIM Chimera
$6.83 /

-0.73 (-9.66%)

Hot Stocks
Chimera falls -7.0% » 09:48
09/22/22
09/22
09:48
09/22/22
09:48
CIM

Chimera

$7.04 /

-0.525 (-6.94%)

Chimera is down -7.0%, or…

Chimera is down -7.0%, or -53c to $7.03.

ShowHide Related Items >><<
CIM Chimera
$7.04 /

-0.525 (-6.94%)

07/17/22 Barclays
Chimera price target lowered to $9 from $11 at Barclays
04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$7.04 /

-0.525 (-6.94%)

CIM Chimera
$7.04 /

-0.525 (-6.94%)

CIM Chimera
$7.04 /

-0.525 (-6.94%)

Over a month ago
Earnings
Chimera reports Q2 EPS 31c, consensus 33c » 07:30
08/04/22
08/04
07:30
08/04/22
07:30
CIM

Chimera

$10.14 /

-0.015 (-0.15%)

Chimera Investment 2Q Net…

Chimera Investment 2Q Net Interest Income $116.89M "Despite the challenging market environment of higher interest rates and wider credit spreads, Chimera remained committed to effectively and efficiently managing its liquidity, liabilities and capital structure during the quarter," said Mohit Marria, CEO and Chief Investment Officer. "Securitizations and secured financing agreements provide stable, long-term financing for Chimera's credit assets. Chimera also repurchased 5.4 million shares of its common stock over the period, which is accretive to our earnings available for distribution."

ShowHide Related Items >><<
CIM Chimera
$10.14 /

-0.015 (-0.15%)

07/17/22 Barclays
Chimera price target lowered to $9 from $11 at Barclays
04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$10.14 /

-0.015 (-0.15%)

CIM Chimera
$10.14 /

-0.015 (-0.15%)

CIM Chimera
$10.14 /

-0.015 (-0.15%)

On The Fly
What You Missed On Wall Street This Morning » 12:05
07/18/22
07/18
12:05
07/18/22
12:05
BA

Boeing

$151.69 /

+3.99 (+2.70%)

, DAL

Delta Air Lines

$31.72 /

+1.635 (+5.43%)

, BAC

Bank of America

$32.47 /

+0.26 (+0.81%)

, GS

Goldman Sachs

$302.70 /

+9.08 (+3.09%)

, MRK

Merck

$94.08 /

-0.88 (-0.93%)

, SGEN

Seagen

$171.64 /

-6.86 (-3.84%)

, FDP

Fresh Del Monte

$30.52 /

+0.3 (+0.99%)

, PARA

Paramount

$25.01 /

+ (+0.00%)

, FOXA

Fox Corp.

$33.40 /

-0.28 (-0.83%)

, YUM

Yum! Brands

$119.15 /

+1.18 (+1.00%)

, GM

General Motors

$33.21 /

+0.35 (+1.07%)

, EAT

Brinker

$23.46 /

+0.47 (+2.04%)

, KHC

Kraft Heinz

$38.60 /

+0.565 (+1.49%)

, MCD

McDonald's

$253.93 /

-0.98 (-0.38%)

, AMRN

Amarin

$1.35 /

-0.005 (-0.37%)

, COIN

Coinbase

$62.12 /

+8.36 (+15.55%)

, GSK

GSK

$41.03 /

-0.23 (-0.56%)

, RYTM

Rhythm Pharmaceuticals

$10.86 /

+0.85 (+8.49%)

, GRAB

Grab Holdings

$2.80 /

+0.29 (+11.58%)

, RCL

Royal Caribbean

$35.59 /

+2.82 (+8.61%)

, NYMT

New York Mortgage

$2.76 /

-0.065 (-2.30%)

, CIM

Chimera

$8.88 /

-0.23 (-2.52%)

, PLD

Prologis

$121.33 /

+0.34 (+0.28%)

, SYF

Synchrony

$32.24 /

+0.83 (+2.64%)

, ASH

Ashland

$101.67 /

+2.99 (+3.03%)

, SCHW

Charles Schwab

$63.10 /

+0.925 (+1.49%)

, GNTY

Guaranty Bancshares

$37.10 /

+0.79 (+2.18%)

, HLN

Haleon

/

+

Get caught up quickly on…

ShowHide Related Items >><<
YUM Yum! Brands
$119.15 /

+1.18 (+1.00%)

SYF Synchrony
$32.24 /

+0.83 (+2.64%)

SGEN Seagen
$171.64 /

-6.86 (-3.84%)

SCHW Charles Schwab
$63.10 /

+0.925 (+1.49%)

RYTM Rhythm Pharmaceuticals
$10.86 /

+0.85 (+8.49%)

RCL Royal Caribbean
$35.59 /

+2.82 (+8.61%)

PLD Prologis
$121.33 /

+0.34 (+0.28%)

PARA Paramount
$25.01 /

+ (+0.00%)

NYMT New York Mortgage
$2.76 /

-0.065 (-2.30%)

MRK Merck
$94.08 /

-0.88 (-0.93%)

MCD McDonald's
$253.93 /

-0.98 (-0.38%)

KHC Kraft Heinz
$38.60 /

+0.565 (+1.49%)

GSK GSK
$41.03 /

-0.23 (-0.56%)

GS Goldman Sachs
$302.70 /

+9.08 (+3.09%)

GRAB Grab Holdings
$2.80 /

+0.29 (+11.58%)

GNTY Guaranty Bancshares
$37.10 /

+0.79 (+2.18%)

GM General Motors
$33.21 /

+0.35 (+1.07%)

FOXA Fox Corp.
$33.40 /

-0.28 (-0.83%)

FDP Fresh Del Monte
$30.52 /

+0.3 (+0.99%)

EAT Brinker
$23.46 /

+0.47 (+2.04%)

DAL Delta Air Lines
$31.72 /

+1.635 (+5.43%)

COIN Coinbase
$62.12 /

+8.36 (+15.55%)

BAC Bank of America
$32.47 /

+0.26 (+0.81%)

BA Boeing
$151.69 /

+3.99 (+2.70%)

ASH Ashland
$101.67 /

+2.99 (+3.03%)

AMRN Amarin
$1.35 /

-0.005 (-0.37%)

BA Boeing
$151.69 /

+3.99 (+2.70%)

07/18/22 Cowen
Cowen believes Aerospace and Defense quarterly results to be mixed
07/15/22 Benchmark
Boeing price target lowered to $200 from $250 at Benchmark
07/14/22 RBC Capital
Boeing price target lowered to $200 from $220 at RBC Capital
07/13/22 JPMorgan
Boeing price target lowered to $188 from $190 at JPMorgan
DAL Delta Air Lines
$31.72 /

+1.635 (+5.43%)

07/17/22 Citi
Citi opens 'positive catalyst watch' on Delta, says Q2 selloff overdone
07/15/22 Jefferies
Delta Air Lines price target lowered to $45 from $50 at Jefferies
07/15/22 Argus
Argus cuts Delta Air Lines to Hold on weaker outlook
07/15/22 Argus
Delta Air Lines downgraded to Hold from Buy at Argus
BAC Bank of America
$32.47 /

+0.26 (+0.81%)

07/12/22 Citi
Bank of America price target lowered to $40 from $47 at Citi
07/12/22 Morgan Stanley
Bank of America price target lowered to $40 from $47 at Morgan Stanley
07/11/22 Jefferies
Bank of America price target lowered to $33 from $43 at Jefferies
07/11/22 Societe Generale
Societe Generale upgrades 'highest quality' Bank of America to Buy
GS Goldman Sachs
$302.70 /

+9.08 (+3.09%)

07/12/22 Citi
Goldman Sachs price target lowered to $360 from $400 at Citi
07/12/22 Morgan Stanley
Goldman Sachs price target lowered to $354 from $418 at Morgan Stanley
07/01/22 RBC Capital
Goldman Sachs price target lowered to $370 from $390 at RBC Capital
07/01/22 Oppenheimer
Oppenheimer says U.S. financial institutions 'dramatically undervalued'
MRK Merck
$94.08 /

-0.88 (-0.93%)

07/18/22 UBS
Merck price target raised to $98 from $76 at UBS
07/12/22 H.C. Wainwright
H.C. Wainwright says Bellus set for 'show down' against Merck's gefapixant
07/08/22 Morgan Stanley
Merck price target raised to $88 from $87 at Morgan Stanley
07/07/22 Daiwa
Merck upgraded to Outperform from Neutral at Daiwa (yesterday)
SGEN Seagen
$171.64 /

-6.86 (-3.84%)

07/08/22 JMP Securities
Seagen price target raised to $196 from $157 at JMP Securities
06/29/22 Raymond James
Seagen initiated with an Outperform at Raymond James
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
FDP Fresh Del Monte
$30.52 /

+0.3 (+0.99%)

08/24/21 Goldman Sachs
Dole initiated with a Buy at Goldman Sachs
PARA Paramount
$25.01 /

+ (+0.00%)

07/18/22 Morgan Stanley
Paramount downgraded to Underweight from Equal Weight at Morgan Stanley
07/14/22 Barclays
Paramount price target lowered to $20 from $24 at Barclays
07/07/22 Citi
Paramount price target lowered to $37 from $44 at Citi
07/06/22 BofA
Paramount price target lowered to $28 from $32 at BofA
FOXA Fox Corp.
$33.40 /

-0.28 (-0.83%)

07/18/22 Morgan Stanley
Fox Corp. downgraded to Equal Weight from Overweight at Morgan Stanley
05/25/22 Deutsche Bank
Fox Corp. price target lowered to $46 from $48 at Deutsche Bank
04/19/22 Rosenblatt
Fox Corp. initiated with a Neutral at Rosenblatt
04/12/22 Vertical Group
Fox Corp. upgraded to Positive from Mixed at Vertical Group
YUM Yum! Brands
$119.15 /

+1.18 (+1.00%)

07/18/22 Morgan Stanley
Yum! Brands price target lowered to $142 from $146 at Morgan Stanley
07/18/22 Goldman Sachs
Yum! Brands upgraded to Buy from Sell at Goldman Sachs
06/09/22 Barclays
Yum! Brands price target lowered to $120 from $124 at Barclays
05/06/22 Guggenheim
Domino's Pizza price target lowered to $370 from $445 at Guggenheim
GM General Motors
$33.21 /

+0.35 (+1.07%)

07/18/22 Deutsche Bank
Deutsche downgrades GM to Hold on growing earnings risk
07/18/22 Deutsche Bank
General Motors downgraded to Hold from Buy at Deutsche Bank
07/14/22 Morgan Stanley
General Motors price target lowered to $42 from $44 at Morgan Stanley
07/05/22 Barclays
General Motors Q2 earnings estimate cut at Barclays
EAT Brinker
$23.46 /

+0.47 (+2.04%)

07/18/22 Morgan Stanley
Brinker price target lowered to $26 from $37 at Morgan Stanley
07/18/22 Goldman Sachs
Brinker downgraded to Neutral from Buy at Goldman Sachs
07/08/22 Wedbush
Wedbush sees Dine Brands, Wingsstop, Wendy's as Best Ideas in restaurants
06/27/22 BofA
Brinker reinstated with an Underperform at BofA
KHC Kraft Heinz
$38.60 /

+0.565 (+1.49%)

07/18/22 Deutsche Bank
Kraft Heinz price target lowered to $47 from $48 at Deutsche Bank
07/18/22 Mizuho
Kraft Heinz initiated with a Buy at Mizuho
06/22/22 BMO Capital
Kraft Heinz upgraded to Outperform from Market Perform at BMO Capital
05/26/22 UBS
UBS cuts Kraft Heinz to Sell, sees private label trade-down risk not priced in
MCD McDonald's
$253.93 /

-0.98 (-0.38%)

07/18/22 Morgan Stanley
McDonald's price target lowered to $285 from $287 at Morgan Stanley
07/07/22 Cleveland Research
McDonald's U.S. comp trends look to have accelerated, says Cleveland Research
07/07/22 Deutsche Bank
McDonald's price target lowered to $263 from $265 at Deutsche Bank
AMRN Amarin
$1.35 /

-0.005 (-0.37%)

05/06/22 JPMorgan
JPMorgan downgrades Amarin to sell on headwinds in U.S., Europe
05/06/22 JPMorgan
Amarin downgraded to Underweight from Neutral at JPMorgan
05/05/22 H.C. Wainwright
Amarin downgraded to Neutral from Buy at H.C. Wainwright
05/05/22 SVB Securities
Amarin downgraded to Market Perform from Outperform at SVB Leerink
COIN Coinbase
$62.12 /

+8.36 (+15.55%)

07/14/22 DA Davidson
Coinbase price target lowered to $90 from $135 at DA Davidson
07/14/22 Mizuho
Coinbase price target lowered to $42 from $45 at Mizuho
07/12/22 JMP Securities
Coinbase price target lowered to $205 from $250 at JMP Securities
07/06/22 Atlantic Equities
Atlantic downgrades Coinbase to Neutral, lowers price target 'materially'
GSK GSK
$41.03 /

-0.23 (-0.56%)

07/15/22 Oppenheimer
Ideaya Biosciences assumed with an Outperform at Oppenheimer
07/15/22 Credit Suisse
GSK plc price target raised to 1,600 GBp from 1,400 GBp at Credit Suisse
06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
05/19/22 Deutsche Bank
GlaxoSmithKline price target raised to 1,750 GBp at Deutsche Bank
RYTM Rhythm Pharmaceuticals
$10.86 /

+0.85 (+8.49%)

07/13/22 Ladenburg
Rhythm Pharmaceuticals price target raised to $23 from $15 at Ladenburg
07/12/22 Goldman Sachs
Rhythm Pharmaceuticals price target raised to $6 from $4 at Goldman Sachs
06/17/22 Needham
Rhythm Pharmaceuticals price target lowered to $25 from $40 at Needham
06/17/22 Stifel
Rhythm Pharmaceuticals price target raised to $25 from $23 at Stifel
GRAB Grab Holdings
$2.80 /

+0.29 (+11.58%)

07/18/22 JPMorgan
JPMorgan upgrades Grab with profitability shifting into 'high gear'
07/18/22 JPMorgan
Grab Holdings upgraded to Overweight from Neutral at JPMorgan
07/07/22 Evercore ISI
Grab Holdings price target lowered to $5 from $6 at Evercore ISI
06/17/22 Deutsche Bank
Grab Holdings initiated with a Buy at Deutsche Bank
RCL Royal Caribbean
$35.59 /

+2.82 (+8.61%)

06/29/22 Barclays
Barclays initiates cruise line space with Royal Caribbean top pick
06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Royal Caribbean initiated with an Overweight at Barclays
06/21/22 Deutsche Bank
Royal Caribbean price target lowered to $50 from $76 at Deutsche Bank
NYMT New York Mortgage
$2.76 /

-0.065 (-2.30%)

07/17/22 Barclays
New York Mortgage price target lowered to $3 from $3.50 at Barclays
07/17/22 Keefe Bruyette
New York Mortgage downgraded to Market Perform at Keefe Bruyette
04/27/22 Barclays
New York Mortgage price target lowered to $3.50 from $4 at Barclays
02/23/22 Keefe Bruyette
New York Mortgage upgraded to Outperform from Market Perform at Keefe Bruyette
CIM Chimera
$8.88 /

-0.23 (-2.52%)

07/17/22 Barclays
Chimera price target lowered to $9 from $11 at Barclays
04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
PLD Prologis
$121.33 /

+0.34 (+0.28%)

07/15/22 Baird
Duke Realty downgraded to Neutral into takeover at Baird
06/30/22 Jefferies
Prologis price target lowered to $146 from $174 at Jefferies
06/14/22 Edward Jones
Duke Realty downgraded to Hold from Buy at Edward Jones
06/06/22 Wells Fargo
Prologis price target lowered to $160 from $184 at Wells Fargo
SYF Synchrony
$32.24 /

+0.83 (+2.64%)

07/13/22 Wells Fargo
Synchrony downgraded to Equal Weight at Wells Fargo on cautious macro view
07/13/22 Wells Fargo
Synchrony downgraded to Equal Weight from Overweight at Wells Fargo
07/12/22 Morgan Stanley
Synchrony price target lowered to $31 from $40 at Morgan Stanley
07/11/22 Keefe Bruyette
Synchrony price target lowered to $46 from $59 at Keefe Bruyette
ASH Ashland
$101.67 /

+2.99 (+3.03%)

07/18/22 Wells Fargo
Ashland price target lowered to $107 from $113 at Wells Fargo
07/06/22 Mizuho
Ashland price target raised to $138 from $135 at Mizuho
04/28/22 Deutsche Bank
Ashland price target raised to $122 from $120 at Deutsche Bank
04/19/22 Mizuho
Ashland price target raised to $135 from $129 at Mizuho
SCHW Charles Schwab
$63.10 /

+0.925 (+1.49%)

07/13/22 Deutsche Bank
Charles Schwab price target raised to $81 from $80 at Deutsche Bank
06/28/22 Deutsche Bank
Charles Schwab price target lowered to $80 from $84 at Deutsche Bank
06/23/22 Redburn
Charles Schwab initiated with a Neutral at Redburn
06/21/22 UBS
Charles Schwab upgraded to Buy from Neutral at UBS
GNTY Guaranty Bancshares
$37.10 /

+0.79 (+2.18%)

07/07/22 Raymond James
Guaranty Bancshares downgraded to Market Perform from Outperform at Raymond James
07/07/22 Raymond James
Guaranty Bancshares downgraded to Market Perform from Outperform at Raymond James
HLN Haleon
/

+

YUM Yum! Brands
$119.15 /

+1.18 (+1.00%)

SYF Synchrony
$32.24 /

+0.83 (+2.64%)

SGEN Seagen
$171.64 /

-6.86 (-3.84%)

SCHW Charles Schwab
$63.10 /

+0.925 (+1.49%)

RYTM Rhythm Pharmaceuticals
$10.86 /

+0.85 (+8.49%)

RCL Royal Caribbean
$35.59 /

+2.82 (+8.61%)

PLD Prologis
$121.33 /

+0.34 (+0.28%)

PARA Paramount
$25.01 /

+ (+0.00%)

NYMT New York Mortgage
$2.76 /

-0.065 (-2.30%)

MRK Merck
$94.08 /

-0.88 (-0.93%)

MCD McDonald's
$253.93 /

-0.98 (-0.38%)

KHC Kraft Heinz
$38.60 /

+0.565 (+1.49%)

GSK GSK
$41.03 /

-0.23 (-0.56%)

GS Goldman Sachs
$302.70 /

+9.08 (+3.09%)

GRAB Grab Holdings
$2.80 /

+0.29 (+11.58%)

GNTY Guaranty Bancshares
$37.10 /

+0.79 (+2.18%)

GM General Motors
$33.21 /

+0.35 (+1.07%)

FOXA Fox Corp.
$33.40 /

-0.28 (-0.83%)

EAT Brinker
$23.46 /

+0.47 (+2.04%)

DAL Delta Air Lines
$31.72 /

+1.635 (+5.43%)

COIN Coinbase
$62.12 /

+8.36 (+15.55%)

CIM Chimera
$8.88 /

-0.23 (-2.52%)

BAC Bank of America
$32.47 /

+0.26 (+0.81%)

BA Boeing
$151.69 /

+3.99 (+2.70%)

ASH Ashland
$101.67 /

+2.99 (+3.03%)

AMRN Amarin
$1.35 /

-0.005 (-0.37%)

  • 13
    Jan
  • 18
    Nov
  • 16
    Nov
YUM Yum! Brands
$119.15 /

+1.18 (+1.00%)

SYF Synchrony
$32.24 /

+0.83 (+2.64%)

SCHW Charles Schwab
$63.10 /

+0.925 (+1.49%)

RCL Royal Caribbean
$35.59 /

+2.82 (+8.61%)

PLD Prologis
$121.33 /

+0.34 (+0.28%)

PARA Paramount
$25.01 /

+ (+0.00%)

MRK Merck
$94.08 /

-0.88 (-0.93%)

MCD McDonald's
$253.93 /

-0.98 (-0.38%)

KHC Kraft Heinz
$38.60 /

+0.565 (+1.49%)

GSK GSK
$41.03 /

-0.23 (-0.56%)

GS Goldman Sachs
$302.70 /

+9.08 (+3.09%)

GRAB Grab Holdings
$2.80 /

+0.29 (+11.58%)

GM General Motors
$33.21 /

+0.35 (+1.07%)

FOXA Fox Corp.
$33.40 /

-0.28 (-0.83%)

FDP Fresh Del Monte
$30.52 /

+0.3 (+0.99%)

EAT Brinker
$23.46 /

+0.47 (+2.04%)

DAL Delta Air Lines
$31.72 /

+1.635 (+5.43%)

COIN Coinbase
$62.12 /

+8.36 (+15.55%)

BAC Bank of America
$32.47 /

+0.26 (+0.81%)

BA Boeing
$151.69 /

+3.99 (+2.70%)

AMRN Amarin
$1.35 /

-0.005 (-0.37%)

YUM Yum! Brands
$119.15 /

+1.18 (+1.00%)

SYF Synchrony
$32.24 /

+0.83 (+2.64%)

SCHW Charles Schwab
$63.10 /

+0.925 (+1.49%)

RYTM Rhythm Pharmaceuticals
$10.86 /

+0.85 (+8.49%)

RCL Royal Caribbean
$35.59 /

+2.82 (+8.61%)

PLD Prologis
$121.33 /

+0.34 (+0.28%)

PARA Paramount
$25.01 /

+ (+0.00%)

MRK Merck
$94.08 /

-0.88 (-0.93%)

MCD McDonald's
$253.93 /

-0.98 (-0.38%)

KHC Kraft Heinz
$38.60 /

+0.565 (+1.49%)

GSK GSK
$41.03 /

-0.23 (-0.56%)

GS Goldman Sachs
$302.70 /

+9.08 (+3.09%)

GRAB Grab Holdings
$2.80 /

+0.29 (+11.58%)

GM General Motors
$33.21 /

+0.35 (+1.07%)

FOXA Fox Corp.
$33.40 /

-0.28 (-0.83%)

EAT Brinker
$23.46 /

+0.47 (+2.04%)

DAL Delta Air Lines
$31.72 /

+1.635 (+5.43%)

COIN Coinbase
$62.12 /

+8.36 (+15.55%)

BAC Bank of America
$32.47 /

+0.26 (+0.81%)

BA Boeing
$151.69 /

+3.99 (+2.70%)

ASH Ashland
$101.67 /

+2.99 (+3.03%)

AMRN Amarin
$1.35 /

-0.005 (-0.37%)

SYF Synchrony
$32.24 /

+0.83 (+2.64%)

SGEN Seagen
$171.64 /

-6.86 (-3.84%)

SCHW Charles Schwab
$63.10 /

+0.925 (+1.49%)

RCL Royal Caribbean
$35.59 /

+2.82 (+8.61%)

PLD Prologis
$121.33 /

+0.34 (+0.28%)

PARA Paramount
$25.01 /

+ (+0.00%)

NYMT New York Mortgage
$2.76 /

-0.065 (-2.30%)

MRK Merck
$94.08 /

-0.88 (-0.93%)

MCD McDonald's
$253.93 /

-0.98 (-0.38%)

KHC Kraft Heinz
$38.60 /

+0.565 (+1.49%)

GSK GSK
$41.03 /

-0.23 (-0.56%)

GS Goldman Sachs
$302.70 /

+9.08 (+3.09%)

GRAB Grab Holdings
$2.80 /

+0.29 (+11.58%)

GM General Motors
$33.21 /

+0.35 (+1.07%)

FOXA Fox Corp.
$33.40 /

-0.28 (-0.83%)

EAT Brinker
$23.46 /

+0.47 (+2.04%)

DAL Delta Air Lines
$31.72 /

+1.635 (+5.43%)

COIN Coinbase
$62.12 /

+8.36 (+15.55%)

CIM Chimera
$8.88 /

-0.23 (-2.52%)

BAC Bank of America
$32.47 /

+0.26 (+0.81%)

BA Boeing
$151.69 /

+3.99 (+2.70%)

Recommendations
Chimera price target lowered to $9 from $11 at Barclays » 21:20
07/17/22
07/17
21:20
07/17/22
21:20
CIM

Chimera

$9.11 /

+0.18 (+2.02%)

Barclays analyst Mark…

Barclays analyst Mark DeVries lowered the firm's price target on Chimera to $9 from $11 and keeps an Underweight rating on the shares. The analyst expects book values to be down meaningfully in Q2 for the mortgage real estate investment trusts as rising rates and volatile spreads pressure asset values. He remains cautious on the space citing the likelihood of continued spread volatility.

ShowHide Related Items >><<
CIM Chimera
$9.11 /

+0.18 (+2.02%)

04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$9.11 /

+0.18 (+2.02%)

CIM Chimera
$9.11 /

+0.18 (+2.02%)

Options
Chimera put volume heavy and directionally bearish » 10:35
07/15/22
07/15
10:35
07/15/22
10:35
CIM

Chimera

$8.90 /

-0.03 (-0.34%)

Bearish flow noted in…

Bearish flow noted in Chimera with 2,677 puts trading, or 3x expected. Most active are Dec-22 8 puts and Jul-22 9 calls, with total volume in those strikes near 2,600 contracts. The Put/Call Ratio is 36.18, while ATM IV is up over 2 points on the day. Earnings are expected on August 3rd.

ShowHide Related Items >><<
CIM Chimera
$8.90 /

-0.03 (-0.34%)

04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$8.90 /

-0.03 (-0.34%)

CIM Chimera
$8.90 /

-0.03 (-0.34%)

Options
Chimera put volume heavy and directionally bearish » 12:55
07/12/22
07/12
12:55
07/12/22
12:55
CIM

Chimera

$9.13 /

+0.09 (+1.00%)

Bearish flow noted in…

Bearish flow noted in Chimera with 6,164 puts trading, or 4x expected. Most active are Jan-24 5 puts and Dec-22 8 puts, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 114, while ATM IV is up nearly 2 points on the day. Earnings are expected on August 3rd.

ShowHide Related Items >><<
CIM Chimera
$9.13 /

+0.09 (+1.00%)

04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays
CIM Chimera
$9.13 /

+0.09 (+1.00%)

Over a quarter ago
Earnings
Chimera reports Q1 EPS 39, consensus 37c » 07:41
05/05/22
05/05
07:41
05/05/22
07:41
CIM

Chimera

$10.95 /

+0.275 (+2.58%)

Reports Q1 book value per…

Reports Q1 book value per share $10.15. "We began to prepare for a higher rate environment in 2021 by maintaining low leverage and optimizing our liability structure which included the re-securitizing $6 billion of our loans with long-term fixed-rate coupons. As rates began to rise this year, we have begun implementation of the next leg our strategy; to acquire higher yielding residential loans while continuing to obtain long-term financing through securitization", said Mohit Marria, CEO and chief investment officer. "This quarter we committed to acquire $807 million of residential re-performing loans and sponsored our first securitization of 2022 with $328 million CIM 2022-R1. We expect these actions to be accretive to earnings immediately."

ShowHide Related Items >><<
CIM Chimera
$10.95 /

+0.275 (+2.58%)

04/27/22 Barclays
Chimera price target lowered to $11 from $14 at Barclays
01/10/22 Barclays
Chimera price target raised to $14 from $11 at Barclays

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.